捷成股份(300182.SZ):自主研發的AI智能創作引擎ChatPV於7月29日正式上線公測
格隆匯7月29日丨捷成股份(300182.SZ)在投資者互動平台表示,公司自主研發的AI智能創作引擎ChatPV於7月29日正式上線公測。此次開放公測的ChatPV將提供影視二創、一鍵成片、數字人、文生視頻等AI智能視頻創作功能,更多功能將陸續上線。現可通過https://chatpv.jetsen.cn/在線訪問,公測階段可憑藉官方發放的邀請碼註冊申請試用,或掃描公司官網宣傳海報上的二維碼申請參與公測。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.